Randomized phase III trial evaluating motivational interviewing and text interventions to optimize adherence to breast cancer endocrine therapy (Alliance A191901): the GETSET protocol

BACKGROUND: Hormone receptor-positive (HR +) breast cancer is the most common type of breast cancer in the USA but has excellent long-term outcomes in recent decades, in part due to effective oral endocrine therapy (ET). ET medications are typically prescribed for 5 to 10 years, depending on the ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Ivory, Joannie, Wheeler, Stephanie B., Drier, Sarah, Gunn, Heather, Zahrieh, David, Paskett, Electra, Naughton, Michelle, Wills, Rachel, Swetel, Kayla, Chow, Selina, Reeder-Hayes, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568920/
https://www.ncbi.nlm.nih.gov/pubmed/37828596
http://dx.doi.org/10.1186/s13063-023-07672-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568920/
https://www.ncbi.nlm.nih.gov/pubmed/37828596
http://dx.doi.org/10.1186/s13063-023-07672-8

Ejemplares similares